New Zealand general practitioners' views on direct-to-consumer advertising (DTCA) of prescription medicines: A qualitative analysis

New Zealand Medical Journal

Volumn 118, Issue 1215, 2005, Pages

  Muabach, Ninya ^a   Hoek, Janet ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; AWARENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; DRUG MARKETING; FEMALE; GENERAL PRACTITIONER; HEALTH STATUS; HUMAN; INCIDENCE; INTERVIEW; MALE; MEDICAL INFORMATION; NEW ZEALAND; PRESCRIPTION; QUALITY CONTROL; QUANTITATIVE ANALYSIS;

EID: 27244450744     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lexchin J, Mintzes B. Direct-to-consumer advertising of prescription drugs: The evidence says no. J Public Policy Marketing. 2002;21:194-202.
2. Hoek J, Gendall P. Direct to consumer advertising of prescription medicines: A consumer survey. Palmerston North: Department of Marketing, Massey University; 2003.
3. Weissman JS, Blumenthal D, Silk AJ, et al. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff. 2004;23:W4.219-33.
4. Toop L, Richards D, Dowell T, et al. Direct to consumer advertising of prescription drugs in New Zealand: For health or for profit? Report to the Minister of Health supporting the case for a ban on DTCA. Dunedin: University of Otago; 2003. Available online. URL: http://www.chmeds.ac.nz/report.htm Accessed May 2005.
5. Weissman JS, Blumenthal D, Silk AJ, et al. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff. 2003;22:W82-W95.
6. Holmer A. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA. 1999;281:380-2.
7. Hollon M. Direct-to-consumer marketing of prescription drugs. JAMA. 1999;281:382-4.
8. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: Trends, impact and implications. Health Aff. 2000;19:110-28.
9. Cockburn J, Pit S. Prescribing behaviour in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations. BMJ. 1997;315:520-3.
10. Bell RA, Wilkes MS, Kravitz RL. Advertisement-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses. J Fam Pract. 1999;48:446-52.
11. Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495-9.
12. Coney S. Direct to consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. J Public Policy Marketing. 2002;21:213-23.
13. Pharmac. Pharmac submission for Ministry of Health review of direct to consumer advertising. Wellington: Pharmac; 2000.
14. Davis J. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs. J Health Comm. 2001;5:349-69.
15. Aitken KJ. Direct-to-consumer advertising of prescription drugs: Physician survey, preliminary results. Washington: FDA, 2003. Available online. URL: http://www.fda.gov/cder/ddmac/globalsummit2003 Accessed May 2005.
16. Hoek J, Gendall P, Calfee J. Direct-to-consumer-advertising of prescription medicine in the United States and New Zealand: An analysis of regulatory approaches and consumer responses. Int J Advertising. 2004;23:197-227.
17. Ministry of Health. Direct-to-consumer advertising of prescription medicines in New Zealand: A discussion paper. Wellington: Ministry of Health, 2000. Available online. URL: http://www.moh.govt.nz/moh.nsf/ea6005dc347e7bd44c2566a40079ae6f/ 60d7a3792a5eb5b7cc256a41000ad997?OpenDocument Accessed May 2005.
18. Ebrahim S. The medicalisation of old age: Should be encouraged. BMJ. 2002;324:861-3.
19. Researched Medicines Industry Association of New Zealand. RMI Code of Practice, Edition 13. Auckland: RMI, 2003. Available online. URL: http://www.rmianz.co.nz/html/publications/publications-3-3.asp Accessed May 2005.